Day One Biopharmaceuticals (DAWN) Amortizatization of Intangibles (2022 - 2025)
Day One Biopharmaceuticals (DAWN) has disclosed Amortizatization of Intangibles for 4 consecutive years, with -$9.4 million as the latest value for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles fell 255.41% year-over-year to -$9.4 million; the TTM value through Dec 2025 reached -$3.6 million, down 151.21%, while the annual FY2025 figure was $3.1 million, 51.32% down from the prior year.
- Amortizatization of Intangibles was -$9.4 million for Q4 2025 at Day One Biopharmaceuticals, down from $800000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $10.1 million in Q4 2023, with the low at -$9.4 million in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $978866.7 across 4 years, with a median of $300000.0 in 2024.
- The largest annual shift saw Amortizatization of Intangibles soared 6007.88% in 2023 before it crashed 255.41% in 2025.
- Over 4 years, Amortizatization of Intangibles stood at $165000.0 in 2022, then soared by 6007.88% to $10.1 million in 2023, then crashed by 39.9% to $6.1 million in 2024, then crashed by 255.41% to -$9.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$9.4 million in Q4 2025, $800000.0 in Q3 2025, and $800000.0 in Q2 2025.